Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion type Assertion NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_head.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion description "[Furthermore, patients with TP53 mutation had a highly elevated risk of dying from breast cancer during the study period (p < 0.001, RR = 10.68) at a median follow-up time of 42 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_provenance.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion evidence source_evidence_literature NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_provenance.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion SIO_000772 9113074 NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_provenance.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion wasDerivedFrom befree-2016 NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_provenance.
- NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_assertion wasGeneratedBy ECO_0000203 NP1371085.RA9nlOay5PjQohNwRiTZ-_aC4uWzl2Ua2DMhEDrfPAEnY130_provenance.